Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Change in Accured Expenses: 2020-2023

Historic Change in Accured Expenses for Surgery Partners (SGRY) over the last 4 years, with FY2023 value amounting to -$1.2 million.

  • Surgery Partners' Change in Accured Expenses rose 9333.33% to -$1.2 million in Q1 2023 from the same period last year, while for Dec 2023 it was -$1.2 million, marking a year-over-year increase of 9794.52%. This contributed to the annual value of -$1.2 million for FY2023, which is 9794.52% up from last year.
  • Latest data reveals that Surgery Partners reported Change in Accured Expenses of -$1.2 million as of FY2023, which was up 9794.52% from -$58.4 million recorded in FY2022.
  • In the past 5 years, Surgery Partners' Change in Accured Expenses registered a high of $135.2 million during FY2020, and its lowest value of -$73.6 million during FY2021.
  • In the last 4 years, Surgery Partners' Change in Accured Expenses had a median value of -$29.8 million in 2022 and averaged $500000.0.
  • As far as peak fluctuations go, Surgery Partners' Change in Accured Expenses crashed by 15443.79% in 2021, and later soared by 9794.52% in 2023.
  • Surgery Partners' Change in Accured Expenses (Annual) stood at $135.2 million in 2020, then plummeted by 154.44% to -$73.6 million in 2021, then rose by 20.65% to -$58.4 million in 2022, then surged by 97.95% to -$1.2 million in 2023.
  • Its Change in Accured Expenses stands at -$1.2 million for FY2023, versus -$58.4 million for FY2022 and -$73.6 million for FY2021.